1. Home
  2. TECX vs ASPI Comparison

TECX vs ASPI Comparison

Compare TECX & ASPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

N/A

Current Price

$28.61

Market Cap

618.9M

Sector

N/A

ML Signal

N/A

Logo ASP Isotopes Inc.

ASPI

ASP Isotopes Inc.

N/A

Current Price

$3.10

Market Cap

507.5M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
TECX
ASPI
Founded
2019
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
618.9M
507.5M
IPO Year
2018
2022

Fundamental Metrics

Financial Performance
Metric
TECX
ASPI
Price
$28.61
$3.10
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
$75.20
$12.00
AVG Volume (30 Days)
197.5K
3.4M
Earning Date
05-07-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
40.70
N/A
EPS
N/A
N/A
Revenue
N/A
$23,849,000.00
Revenue This Year
N/A
$68.41
Revenue Next Year
N/A
$126.69
P/E Ratio
N/A
N/A
Revenue Growth
N/A
475.48
52 Week Low
$14.39
$3.30
52 Week High
$39.53
$14.49

Technical Indicators

Market Signals
Indicator
TECX
ASPI
Relative Strength Index (RSI) 39.61 31.90
Support Level $27.53 N/A
Resistance Level $31.39 $4.45
Average True Range (ATR) 2.27 0.23
MACD -0.57 -0.07
Stochastic Oscillator 5.14 8.09

Price Performance

Historical Comparison
TECX
ASPI

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About ASPI ASP Isotopes Inc.

ASP Isotopes Inc is a materials company focused on producing and commercializing enriched isotopes for the nuclear medicine, healthcare, green energy, and quantum computing industries. Currently, the company has three operating segments: (i) nuclear fuels, (ii) specialist isotopes and related services, and (iii) construction services. Using proprietary technology-the Aerodynamic Separation Process (ASP)-the company enriches isotopes in South Africa, targeting high-value, low-volume markets to reduce reliance on foreign supply chains. Geographically, the company operates in South Africa, Hong Kong and United States generating key revenue from the Hong Kong region.

Share on Social Networks: